ShareholdingJun 3, 2026, 08:08 AM
Summit Therapeutics Affiliates & Executives to Buy Shares via ATM
AI Summary
Summit Therapeutics Inc.'s Audit Committee and all independent directors have approved company affiliates to purchase shares of common stock under its existing at-the-market (ATM) offering. Separately, Co-Chief Executive Officers Robert Duggan and Mahkam Zanganeh, along with Chief Operating Officer and Chief Financial Officer Manmeet Soni, have indicated their likely intent to purchase shares under the ATM in the near term, though no specific number of shares or binding commitments have been made.
Key Highlights
- Summit Therapeutics' Audit Committee and independent directors approved company affiliates to purchase common stock.
- Purchases will occur under the previously disclosed at-the-market (ATM) offering with JP Morgan Securities LLC.
- Co-CEO Robert Duggan, Co-CEO Mahkam Zanganeh, and COO/CFO Manmeet Soni intend to purchase shares.
- Executives have not specified the number of shares or made formal binding commitments.
- Any executive purchases would be at the prevailing market bid price or better.
Price Impact
More from SMMT